METTL3 and chronic myelogenous leukemia, BCR-ABL1 positive: Specifically, METTL3 regulates PTEN mRNA instability to reduce PTEN protein expression and cause continuous activation of the PI3K/AKT pathway in chronic myelocytic leukemia cells [52].